Colon cancer targeting using conjugates biomaterial 5-flurouracil

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 780-788

  Jaferian, Soleiman ^a   Negahdari, Babak ^b   Eatemadi, Ali ^a,b  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 Flurouracil; 5 FU; Colon cancer; Drug delivery; Polymer

Indexed keywords

ALGINIC ACID; BIOMATERIAL; BOVINE SERUM ALBUMIN; DRUG CARRIER; EUDRAGIT; FLUOROURACIL; GUAR GUM; NANOPARTICLE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE; ANTINEOPLASTIC AGENT;

COLON CANCER; DRUG BINDING SITE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; ANIMAL; COLONIC NEOPLASMS; METABOLISM; PATHOLOGY; PROCEDURES; TRENDS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; FLUOROURACIL; HUMANS;

EID: 84990944630     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.10.004     Document Type: Review

References (78)

1. [1] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136 (2015), E359–E386, 10.1002/ijc.29210.
2. [2] I.A. for R. on C.W.H.O. Iarc., GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012., Globocan. (2012) 1–6. doi:10.1002/ijc.27711.
3. [3] Society, A.C., Colorectal cancer facts & figs. 2014–2016, color. Cancer Facts Fig., 2014, 1–32.
4. [4] Aiyelabegan, H.T., Zaidi, S.S.Z., Fanuel, S., Eatemadi, A., Ebadi, M.T.K., Sadroddiny, E., Albumin-based biomaterial for lungs tissue engineering applications. Int. J. Polym. Mater. Polym. Biomater., 2016.
5. [5] Beiranvand, S., Eatemadi, A., Karimi, A., New updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles. Nanoscale Res. Lett. 11 (2016), 1–10.
6. [6] Daraee, H., Eatemadi, A., Abbasi, E., Fekri Aval, S., Kouhi, M., Akbarzadeh, A., Application of gold nanoparticles in biomedical and drug delivery. Artif. Cells Nanomed. Biotechnol. 44 (2016), 410–422.
7. [7] Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., Akbarzadeh, A., Application of liposomes in medicine and drug delivery. Artif. Cells Nanomed. Biotechnol. 44 (2016), 381–391.
8. [8] Badparva, E., Sadraee, J., Kheirandish, F., Genetic diversity of Blastocystis isolated from cattle in Khorramabad, Iran. Jundishapur J. Microbiol., 8, 2015, 10.5812/jjm.14810.
9. [9] Seidi, K., Eatemadi, A., Mansoori, B., Jahanban-Esfahlan, R., Farajzadeh, D., Nanomagnet-based detoxifying machine: an alternative/complementary approach in HIV therapy. J. AIDS Clin. Res., 2014, 2014.
10. [10] Mohammadian, F., Eatemadi, A., Drug loading and delivery using nanofibers scaffolds. Artif. Cells Nanomed. Biotechnol., 2016, 1–8.
11. [11] Mellatyar, H., Akbarzadeh, A., Rahmati, M., Ghalhar, M.G., Etemadi, A., Nejati-Koshki, K., Zarghami, N., Barkhordari, A., Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac. J. Cancer Prev. 15 (2014), 8693–8698.
12. [12] Ghafarzadeh, M., Eatemadi, A., Fakhravar, Z., Human amniotic fluid derived mesenchymal stem cells cause an anti-cancer effect on breast cancer cell line in vitro. Cell. Mol. Biol. 2016 (2016), 102–106.
13. [13] Keene, K.S., Rich, T.A., Penberthy, D.R., Shepard, R.C., Adams, R., Jones, R.S., Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005), 97–103, 10.1016/j.ijrobp.2004.08.053.
14. [14] Eatemadi, A., Darabi, M., Afraidooni, L., Zarghami, N., Daraee, H., Eskandari, L., Mellatyar, H., Akbarzadeh, A., Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Artif. Cells Nanomed. Biotechnol. 44 (2016), 1008–1017.
15. [15] Eatemadi, A., Daraee, H., Karimkhanloo, H., Kouhi, M., Zarghami, N., Akbarzadeh, A., Abasi, M., Hanifehpour, Y., Joo, S.W., Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res. Lett. 9 (2014), 1–13.
16. [16] Eatemadi, A., Daraee, H., Zarghami, N., Melat Yar, H., Akbarzadeh, A., Nanofiber: synthesis and biomedical applications. Artif. Cells Nanomed. Biotechnol. 44 (2016), 111–121.
17. [17] Mohammadzadeh, S., Shariatpanahi, M., Hamedi, M., Ahmadkhaniha, R., Samadi, N., Ostad, S.N., Chemical composition, oral toxicity and antimicrobial activity of Iranian propolis. Food Chem. 103 (2007), 1097–1103, 10.1016/j.foodchem.2006.10.006.
18. [18] Hoosain, F.G., Choonara, Y.E., Tomar, L.K., Kumar, P., Tyagi, C., Du Toit, L.C., Pillay, V., Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. Biomed. Res. Int., 2015, 2015, 10.1155/2015/484963.
19. [19] Badparva, E., Kheirandish, F., Ebrahimzade, F., Prevalence of intestinal parasites in Lorestan Province, West of Iran. Asian Pacific J. Trop. Dis. 4 (2014), S728–S732, 10.1016/S2222-1808(14)60716-7.
20. [20] Clares, B., Biedma-Ortiz, R.A., Sáez-Fernández, E., Prados, J.C., Melguizo, C., Cabeza, L., Ortiz, R., Arias, J.L., Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer. Eur. J. Pharm. Biopharm. 85 (2013), 329–338, 10.1016/j.ejpb.2013.01.028.
21. [21] Ahmadinejad, M., Aliepour, A., Anbari, K., Kaviani, M., Ganjizadeh, H., Nadri, S., Foroutani, N., Meysami, M., Almasi, V., Fine-needle aspiration touch imprint, and crush preparation cytology for diagnosing thyroid malignancies in thyroid nodules. Indian J. Surg. 77 (2015), 480–483.
22. [22] Haidari, M., Azargoon, A., Mahmoudvand, H., Almasi, V., Pournia, Y., Khorramabadi, M.S., Complications of primary realignment of posterior urethral disruption after pelvic trauma. Trauma Mon. 19 (2014), 23–25, 10.5812/traumamon.13523.
23. [23] Mahmoudvand, H., Fallahi, S., Mahmoudvand, H., Shakibaie, M., Harandi, M.F., Dezaki, E.S., Efficacy of Myrtus communis L. to inactivate the hydatid cyst protoscoleces. J. Investig. Surg., 2015, 1–7.
24. [24] Nadri, S., Teimori, H., Sabzi, F., Hassani, V., Mahmoudvand, H., Base deficit in immediate postoperative period of open heart surgery and outcome of patients. Acta Med. Iran 1 (2016), 227–232 (n.d.).
25. [25] Nadri, S., Mahmoudvand, H., Ahmadinejad, M., Farrokhfar, M., Obeidavi, Z., Effect of oral Gabapentinon post-operative pain, morphine consumption, nausea and vomiting in patients with urgent appendectomy: a randomized double-blind placebo-controlled trial. Int. J. Adv. Biol. Biomed. Res. 4 (2016), 202–207.
26. [26] Gulbake, A., Jain, A., Jain, A., Jain, A., Jain, S.K., Insight to drug delivery aspects for colorectal cancer. World J. Gastroenterol. 22 (2016), 582–599.
27. [27] Safa, F.K., Shahsavari, G., Abyaneh, R.Z., Glutathione s-transferase M1 and T1 genetic polymorphisms in Iranian patients with glaucoma. Iran. J. Basic Med Sci. 17 (2014), 332–336.
28. [28] M. Namdari, A. Esmaeeli, B. Baharvand, S. Nadri, S. Saket, M.J. Tarahi, Y. Shirkani, A. Sepahvand, complement factors in acute myocardial infarction and unstable angina, 2005.
29. [29] Sabzi, F., Hassani, V., Nadri, S., Mahmoudvand, H., Teimori, H., Base deficit in immediate postoperative period of open heart surgery and outcome of patients. Acta Med. Iran. 45 (2007), 227–232.
30. [30] F. Sabzi, H. Tetmouri, S. Nadri, A comparison of effects of Diazepam and Midazolam on Ketamine induced postoperative Hallucination (2006).
31. [31] B. Sadri, S. Nadri, S.B. Pousti, H. Mahmoudvand, Clonidine decreased intraoperative bleeding in rhinoplasty (2007).
32. [32] Ahmadvand, H., Noori, A., Dehnoo, M.G., Bagheri, S., Cheraghi, R.A., Hypoglycemic, hypolipidemic and antiatherogenic effects of oleuropein in alloxan-induced Type 1 diabetic rats. Asian Pacific J. Trop. Dis., 4, 2014, 10.1016/S2222-1808(14)60481-3.
33. [33] Singh, P., Devi, A.R., Sharma, H.R., Sharma, H.M., International journal of current research and academic review. Int. J. Curr. Res. Aca. Rev. 3 (2015), 102–114.
34. [34] Teymouri, H., Mahmoudvand, H., Tarrahi, M., A comparison of pneumotorax and phrenic nerve pulsy complications using the methods: supraclavicular nerve block. Routine and Ten Degree Cephalic Route, 2004.
35. [35] Vahabi, S., Nadri, S., Izadi, F., The effects of gabapentin on severity of post spinal anesthesia headache. Pak. J. Pharm. Sci. 27 (2014), 1203–1207.
36. [36] Akbari, S., Vahabi, S., Kazemi, A.H., Knowledge of women working in Hospitals of Lorestan Medical Sciences University about smoking effects on fertility. J. Reprod. Infertil., 3, 2002.
37. [37] Akbari, S., Vahabi, S., Khaksarian, M., others, A Study of β-Human Chorionic Gonadotropin Level in Preeclamptic and Normotensive Pregnant Women. Res. J. Biol. Sci. 4 (2009), 468–471.
38. [38] Coskun, K.O., Popov, A.F., Coskun, S.T., Blanz, U., Bockhorst, K., El Arousy, M., Weitkemper, H.H., Hinz, J., Körfer, R., Spadavecchia, L., others, CURRENT ISSUE MINERVA PEDIATRICA. Minerva Pediatr. 62 (2010), 233–237.
39. [39] N. Lorzadeh, M. Ghafarzadeh, S. Vahabi, G.H.R. Lashgarara, PREGNANCY OUTCOME FOLLOWING M MR VACCINATION, 2007.
40. [40] Vahabi, S., Heidari, M., Ahmadinejad, M., Akhlaghi, J., Birjandi, M., Comparison of local anesthetic effects of tramadol and lidocaine used subcutaneously in minor surgeries with local anesthesia. Middle East J. Anesthesiol. 21 (2011), 9–14.
41. [41] Vahabi, S., Akhlaghi, J., T606 comparison of local anesthetic effects of tramadol and lidocaine used subcutaneously in minor surgeries with local anesthesia. Eur. J. Pain Suppl., 5, 2011, 82.
42. [42] Vahabi, S., Haidari, M., Akbari Torkamani, S., Gorbani Vaghei, A., Current issue minerva pediatrica. Minerva Pediatr. 62 (2010), 249–252.
43. [43] Vahabi, S., Haidari, M., Akbari, T.S., Gorbani, V.A., New assessment of relationship between Apgar score and early neonatal mortality. Minerva Pediatr. 62 (2010), 249–252.
44. [44] Vahabi, S., Shoja, T., S275 effect of postoperative topical administration of magnesium sulfate on pain relief in pediatric adenotonsillectomy. Eur. J. Pain Suppl., 5, 2011, 243.
45. [45] Vahabi, S., Shoja, T., Chaibakhsh, S., Khak, M., Saljoughi, N., Effect of postoperative topical administration of magnesium sulfate on pain relief in paediatric adenotonsillectomy: A randomised controlled study. HK J Paediatr. 17 (2012), 109–114.
46. [46] Smitha, K.T., Anitha, A., Furuike, T., Tamura, H., Nair, S.V., Jayakumar, R., In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Colloids Surf. B: Biointerfaces 104 (2013), 245–253, 10.1016/j.colsurfb.2012.11.031.
47. [47] Zhang, Y., Zhang, Q., Zha, L., Yang, W., Wang, C., Jiang, X., Fu, S., Preparation, characterization and application of pyrene-loaded methoxy poly(ethylene glycol)-poly(lactic acid) copolymer nanoparticles. Colloid Polym. Sci. 282 (2004), 1323–1328, 10.1007/s00396-004-1068-5.
48. [48] Zhao, H., Wu, F., Cai, Y., Chen, Y., Wei, L., Liu, Z., Yuan, W., Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres. Int. J. Pharm. 450 (2013), 235–240, 10.1016/j.ijpharm.2013.04.051.
49. [49] Elyagoby, A., Layas, N., Wong, T.W., Colon-specific delivery of 5-fluorouracil from zinc pectinate pellets through In Situ intracapsular ethylcellulose-pectin plug formation. J. Pharm. Sci. 102 (2013), 604–616, 10.1002/jps.23388.
50. [50] Vats, A., Pathak, K., Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas. Ther. Deliv. 3 (2012), 1281–1295, 10.4155/tde.12.116.
51. [51] Kanwar, J.R., Mahidhara, G., Kanwar, R.K., Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomedicine (London) 7 (2012), 1521–1550, 10.2217/nnm.12.29.
52. [52] Choi, K.Y., Jeon, E.J., Yoon, H.Y., Lee, B.S., Na, J.H., Min, K.H., Kim, S.Y., Myung, S.J., Lee, S., Chen, X., Kwon, I.C., Choi, K., Jeong, S.Y., Kim, K., Park, J.H., Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials 33 (2012), 6186–6193, 10.1016/j.biomaterials.2012.05.029.
53. [53] Shantha, K.L., Ravichandran, P., Rao, K.P., Azo polymeric hydrogels for colon targeted drug delivery. Biomaterials 16 (1995), 1313–1318, 10.1016/0142-9612(95)91046-2.
54. [54] Yassin, A.E.B., Khalid Anwer, M.D., Mowafy, H.A., El-Bagory, I.M., Bayomi, M.A., Alsarra, I.A., Optimization of 5-fluorouracil solid-lipid nanoparticles: A preliminary study to treat colon cancer. Int. J. Med. Sci. 7 (2010), 398–408, 10.7150/ijms.7.398.
55. [55] Lagdive, S.S., Lagdive, S.B., Mani, A., Anarthe, R., Pendyala, G., Pawar, B., Marawar, P.P., Correlation of mast cells in periodontal diseases. J. Indian Soc. Periodontol. 17 (2013), 63–67, 10.4103/0972-124X.107500.
56. [56] Fernández-Agulló, A., Pereira, E., Freire, M.S., Valentão, P., Andrade, P.B., González-Álvarez, J., Pereira, J.A., Influence of solvent on the antioxidant and antimicrobial properties of walnut (Juglans regia L.) green husk extracts. Ind. Crops Prod. 42 (2013), 126–132, 10.1016/j.indcrop.2012.05.021.
57. [57] Beiranvand, S., Noaparast, M., Eslamizade, N., Saeedikia, S., The effects of religion and spirituality on postoperative pain, Hemodynamic functioning and anxiety after cesarean section. Acta Med. Iran 52 (2014), 909–915.
58. [58] Longley, D.B., Harkin, D.P., Johnston, P.G., 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer. 3 (2003), 330–338, 10.1038/nrc1074.
59. [59] André, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Bonetti, A., Clingan, P., Bridgewater, J., Rivera, F., de Gramont, A., Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J. Clin. Oncol. 27 (2009), 3109–3116, 10.1200/JCO.2008.20.6771.
60. [60] Sargent, D.J., Marsoni, S., Monges, G., Thibodeau, S.N., Labianca, R., Hamilton, S.R., French, A.J., Kabat, B., Foster, N.R., Torri, V., Ribic, C., Grothey, A., Moore, M., Zaniboni, A., Seitz, J.F., Sinicrope, F., Gallinger, S., Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. 28 (2010), 3219–3226, 10.1200/JCO.2009.27.1825.
61. [61] Irimia-Vladu, M., Troshin, P.A., Reisinger, M., Shmygleva, L., Kanbur, Y., Schwabegger, G., Bodea, M., Schwödiauer, R., Mumyatov, A., Fergus, J.W., Razumov, V.F., Sitter, H., Sariciftci, N.S., Bauer, S., Biocompatible and biodegradable materials for organic field-effect transistors. Adv. Funct. Mater. 20 (2010), 4069–4076, 10.1002/adfm.201001031.
62. [62] Artzi, N., Oliva, N., Puron, C., Shitreet, S., Artzi, S., bon Ramos, A., Groothuis, A., Sahagian, G., Edelman, E.R., In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat. Mater. 10 (2011), 704–709, 10.1038/nmat3095.
63. [63] Pitout, J.D.D., Nordmann, P., Laupland, K.B., Poirel, L., Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56 (2005), 52–59, 10.1093/jac/dki166.
64. [64] Nagarwal, R.C., Kumar, R., Pandit, J.K., Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: In vitro characterization and in vivo study in rabbit eye. Eur. J. Pharm. Sci. 47 (2012), 678–685, 10.1016/j.ejps.2012.08.008.
65. [65] Safa, F.K., Shahsavari, G., Miraftabi, A., Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma among Iranian population?. Acta Med. Iran. 53 (2015), 112–116.
66. [66] Lepoittevin, B., Devalckenaere, M., Pantoustier, N., Alexandre, M., Kubies, D., Calberg, C., Jérôme, R., Dubois, P., Poly((-caprolactone)/clay nanocomposites prepared by melt intercalation: mechanical, thermal and rheological properties. Polymer (Guildf). 43 (2002), 4017–4023, 10.1016/S0032-3861(02)00229-X.
67. [67] Sinha, V.R., Bansal, K., Kaushik, R., Kumria, R., Trehan, A., Poly-epsilion-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278 (2004), 1–23, 10.1016/j.ijpharm.2004.01.044.
68. [68] Naksuriya, O., Okonogi, S., Schiffelers, R.M., Hennink, W.E., Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 35 (2014), 3365–3383, 10.1016/j.biomaterials.2013.12.090.
69. [69] Rahman, Z., Kohli, K., Khar, R.K., Ali, M., a Charoo, N., a a Shamsher, A., Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech 7 (2006), E1–E9, 10.1208/pt070247.
70. [70] She, X., Chen, L., Velleman, L., Li, C., Zhu, H., He, C., Wang, T., Shigdar, S., Duan, W., Kong, L., Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery. J. Colloid Interface Sci. 445 (2015), 151–160, 10.1016/j.jcis.2014.12.053.
71. [71] Lamprecht, A., Yamamoto, H., Takeuchi, H., Kawashima, Y., Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release. Eur. J. Pharm. Biopharm. 59 (2005), 367–371, 10.1016/j.ejpb.2004.09.005.
72. [72] Sierra, M., Garcia, J.J., Fernandez, N., Diez, M.J., Calle, A.P., Sahagun, A.M., Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur. J. Clin. Nutr. 55 (2001), 235–243, 10.1038/sj.ejcn.1601147.
73. [73] Fadaeian, G., Shojaosadati, S.A., Kouchakzadeh, H., Shokri, F., Soleimani, M., Targeted delivery of 5-fluorouracil with monoclonal antibody modified bovine serum albumin nanoparticles. Iran. J. Pharm. Res. 14 (2015), 395–405.
74. [74] Sahoo, S.K., Panyam, J., Prabha, S., Labhasetwar, V., Residual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 82 (2002), 105–114, 10.1016/S0168-3659(02)00127-X.
75. [75] Matsumura, Y., Kataoka, K., Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 100 (2009), 572–579, 10.1111/j.1349-7006.2009.01103.x.
76. [76] Namdari, P., Daraee, H., Eatemadi, A., Recent advances in silicon nanowire biosensors: synthesis methods properties, and applications. Nanoscale Res. Lett., 11, 2016, 406.
77. [77] Xu, C., Zhang, J.S., Mo, Y., Tan, R.X., Calcium pectinate capsules for colon-specific drug delivery. Drug Dev. Ind. Pharm. 31 (2005), 127–134, 10.1081/DDC-200046990.
78. [78] André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., Tabah-Fisch, I., de Gramont, A., Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350 (2004), 2343–2351, 10.1056/NEJMoa032709.